Dodge & Cox's REGN Position
Regeneron Pharmaceuticals, Inc. — 10 quarters (Q4 2023 to Q4 2025)
Current Shares
4.60M
Current Value
$3.55B
Peak Shares
4.60M
Q4 2025
Overall Change
+94%
Shares Over Time
Q4 2023
2.37M
Q1 2024
2.36M
0%
Q2 2024
2.32M
-2%
Q3 2024
2.31M
0%
Q4 2024
2.32M
0%
Q1 2025
2.32M
0%
Q2 2025
3.83M
+65%
Q3 2025
4.55M
+19%
Q3 2025
4.55M
0%
Q4 2025
4.60M
+1%
Quarterly Detail
| Quarter | Shares | Value | $/Share | Change |
|---|---|---|---|---|
| Q4 2025 | 4.60M | $3.55B | $771.87 | +1% |
| Q3 2025 | 4.55M | $2.56B | $562.27 | 0% |
| Q3 2025 | 4.55M | $2.56B | $562.27 | +19% |
| Q2 2025 | 3.83M | $2.01B | $525.00 | +65% |
| Q1 2025 | 2.32M | $1.47B | $634.23 | 0% |
| Q4 2024 | 2.32M | $1.65B | $712.33 | 0% |
| Q3 2024 | 2.31M | $2.43B | $1051.24 | 0% |
| Q2 2024 | 2.32M | $2.43B | $1051.03 | -2% |
| Q1 2024 | 2.36M | $2.27B | $962.49 | 0% |
| Q4 2023 | 2.37M | $2.08B | $878.29 | New |